Natrunix Versus Methotrexate in Rheumatoid Arthritis

Clinical trial NCT05363917 · UNKNOWN

Trial details

NCT number: NCT05363917
Sponsor: XBiotech, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2022-06-15
Primary completion: 2022-12-15
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.